Moderna to Ask for Clearance for Combination COVID-Influenza Vaccine

Date:

June 30, 2025

The company says positive results from a clinical trial is spurring the move.

Moderna to Ask for Clearance for Combination COVID-Influenza Vaccine — A health care worker prepares a vaccine in New York City in a file photograph. Michael M. Santiago/Getty Images

6/30/2025|Updated: 6/30/2025

Moderna is going to ask regulators to approve its combination vaccine against COVID-19 and influenza, the company said on June 30.

The company said a phase 3 study evaluating its influenza vaccine candidate, mRNA-1010—which utilizes the same messenger ribonucleic acid (mRNA) platform as its COVID-19 vaccine—showed positive effectiveness.

Zachary Stieber

Senior Reporter

Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]

Author’s Selected Articles

About the author: Zachary Stieber

Tell us something about yourself.

European Union Says Tech Laws ‘Off the Table’ in US Trade Talks

A Tale of Two Quarters: Wall Street Weathers Tariff Whiplash

Zachary Stieber

Moderna to Ask for Clearance for Combination COVID-Influenza Vaccine

More like this
Related

Chinese Researcher Charged With Smuggling E. Coli Into the US

Wall Street Review: Stocks End Week Mixed Amid Bulls-Bears Tug of War

Visa, Mastercard to Pay $167.5 Million to Settle ATM User Fee Lawsuit

Las Vegas Locals Say Hidden Fees, Less Value Are Driving Away Tourists

Moderna to Ask for Clearance for Combination COVID-Influenza Vaccine

More like thisRelated

Chinese Researcher Charged With Smuggling E. Coli Into the US

Wall Street Review: Stocks End Week Mixed Amid Bulls-Bears Tug of War

Visa, Mastercard to Pay $167.5 Million to Settle ATM User Fee Lawsuit

Las Vegas Locals Say Hidden Fees, Less Value Are Driving Away Tourists

More like this
Related